Opko Health, Inc. SEC filings OPK
Opko Health, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Sep 14, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 15, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Other events
|
Oct 2, 2026 | Sep 30, 2026 |
| 10-Q/A | Amended quarterly report | Aug 28, 2026 | Jun 30, 2026 |
| 10-Q/A | Amended quarterly report | Aug 28, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 14, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Jul 27, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 27, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 18, 2026 |
| DEFA14A | Additional proxy material | May 15, 2026 | — |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| 10-Q | Quarterly report | Apr 28, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2026 | Mar 18, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 10-Q | Quarterly report | Oct 29, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 15, 2025 | Sep 15, 2025 |
| 10-Q | Quarterly report | Jul 31, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Officer or director change
|
May 29, 2025 | May 27, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 23, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 1, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 28, 2025 | Mar 27, 2025 |
| 10-K/A | Amended annual report | Mar 21, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Mar 14, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 14, 2025 | — |
| DEF 14A | Proxy statement | Mar 14, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 11, 2025 | Mar 10, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2025 | Jan 15, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Agreement ended, Acquisition or sale of assets, Regulation FD disclosure
|
Sep 16, 2024 | Sep 16, 2024 |
| DEFR14A | Form defr14a | Aug 30, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2024 | Jul 24, 2024 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jul 17, 2024 | Jul 17, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Mar 29, 2024 | Mar 28, 2024 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 28, 2024 | Mar 27, 2024 |
| ARS | Annual report to shareholders | Mar 7, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 1, 2024 | Dec 31, 2023 |
| NT 10-K | Form nt 10-k | Mar 1, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Feb 29, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| PRE 14A | Preliminary proxy statement | Feb 16, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 9, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Other events
|
Jan 24, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Jan 9, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Other events
|
Jan 5, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 4, 2024 | Jan 3, 2024 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Oct 31, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2023 | Sep 28, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 30, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Officer or director change
|
May 19, 2023 | May 18, 2023 |
| DEFA14A | Additional proxy material | May 17, 2023 | — |
| S-8 | Employee stock plan registration | May 15, 2023 | — |
| 10-Q | Quarterly report | May 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 3, 2023 | May 3, 2023 |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | — |
| 8-K |
Current report
Material agreement
|
Mar 8, 2023 | Mar 8, 2023 |
| 10-K | Annual report | Feb 27, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 10, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Other events
|
Jan 3, 2023 | Jan 3, 2023 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 16, 2022 | Aug 16, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Jul 15, 2022 | Jul 14, 2022 |
| DEFA14A | Additional proxy material | Jun 3, 2022 | — |
| DEF 14A | Proxy statement | Jun 3, 2022 | Jun 3, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
May 13, 2022 | May 9, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
May 4, 2022 | Apr 29, 2022 |
| 10-K/A | Amended annual report | May 2, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 27, 2022 | Apr 21, 2022 |
| 8-K |
Current report
Other events
|
Apr 20, 2022 | Apr 15, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 24, 2022 | Jan 21, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 18, 2022 | Jan 14, 2022 |
| 10-Q | Quarterly report | Oct 28, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2021 | Oct 28, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 3, 2021 | Aug 30, 2021 |
| 10-Q | Quarterly report | Jul 29, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 12, 2021 | Jul 6, 2021 |
| 8-K |
Current report
Agreement ended, Shareholder vote results
|
Jun 25, 2021 | Jun 24, 2021 |
| 8-K |
Current report
Material agreement
|
Jun 23, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Material agreement
|
Jun 21, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Agreement ended, Unregistered share sale, Other events
|
May 21, 2021 | May 17, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 7, 2021 | May 6, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 24, 2021 |
| 10-Q | Quarterly report | Apr 28, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 28, 2021 | Apr 28, 2021 |
| 8-K |
Current report
Material agreement
|
Mar 17, 2021 | Mar 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2021 | Mar 1, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 22, 2021 | Feb 19, 2021 |
| 10-K | Annual report | Feb 18, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 18, 2021 | Feb 18, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Feb 5, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 1, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2021 | Jan 13, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 21, 2020 | Dec 18, 2020 |
| 10-Q | Quarterly report | Oct 29, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2020 | Oct 29, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2020 | Sep 15, 2020 |
| 10-Q | Quarterly report | Jul 31, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 31, 2020 | Jul 27, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 23, 2020 | Jul 22, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 21, 2020 | Jul 20, 2020 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 26, 2020 | Jun 25, 2020 |
| 8-K |
Current report
Material agreement
|
May 15, 2020 | May 12, 2020 |
| 10-Q | Quarterly report | May 6, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2020 | Apr 30, 2020 |
| DEFA14A | Additional proxy material | Apr 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 25, 2020 |
| 10-K | Annual report | Mar 2, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2020 | Feb 20, 2020 |
| 8-K |
Current report
Officer or director change
|
Jan 8, 2020 | Jan 6, 2020 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2019 | Nov 1, 2019 |
| 8-K |
Current report
Material agreement
|
Oct 29, 2019 | Oct 24, 2019 |
| 424B5 | Prospectus supplement | Oct 25, 2019 | — |
| 424B5 | Prospectus supplement | Oct 24, 2019 | — |
| 424B5 | Prospectus supplement | Oct 22, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 23, 2019 | Sep 21, 2019 |
| 10-Q | Quarterly report | Aug 7, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2019 | Aug 7, 2019 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 29, 2019 | Jul 24, 2019 |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2019 | Jul 1, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Jun 21, 2019 | Jun 20, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2019 | Jun 3, 2019 |
| 8-K |
Current report
Other events
|
May 17, 2019 | May 14, 2019 |
| 10-Q | Quarterly report | May 8, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2019 | May 7, 2019 |
| DEFA14A | Additional proxy material | Apr 29, 2019 | — |
| DEFA14A | Additional proxy material | Apr 26, 2019 | — |
| DEF 14A | Proxy statement | Apr 26, 2019 | Jun 20, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2019 | Apr 15, 2019 |
| 10-K | Annual report | Mar 1, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2019 | Feb 27, 2019 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Feb 7, 2019 | Feb 4, 2019 |
| 424B2 | Prospectus | Feb 6, 2019 | — |
| 424B7 | Filing | Feb 5, 2019 | — |
| FWP | Free writing prospectus | Feb 5, 2019 | — |
| 424B5 | Prospectus supplement | Feb 4, 2019 | — |
| S-3ASR | Automatic shelf registration | Jan 29, 2019 | — |
| 8-K |
Current report
Other events
|
Jan 29, 2019 | Jan 28, 2019 |
| 8-K |
Current report
Other events
|
Jan 8, 2019 | Jan 4, 2019 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 27, 2018 | Dec 27, 2018 |
| UPLOAD | Letter from the SEC | Dec 26, 2018 | — |
| CORRESP | Letter to the SEC | Dec 4, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2018 | — |
| 10-Q | Quarterly report | Nov 9, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Regulation FD disclosure
|
Nov 9, 2018 | Nov 9, 2018 |
| CORRESP | Letter to the SEC | Oct 11, 2018 | — |
| CORRESP | Letter to the SEC | Oct 5, 2018 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 14, 2018 | Sep 14, 2018 |
| UPLOAD | Letter from the SEC | Sep 13, 2018 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 11, 2018 | Sep 7, 2018 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2018 | Sep 7, 2018 |
| CORRESP | Letter to the SEC | Aug 17, 2018 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2018 | Aug 7, 2018 |
| 10-Q | Quarterly report | Aug 7, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2018 | Aug 7, 2018 |
| UPLOAD | Letter from the SEC | Aug 3, 2018 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 22, 2018 | Jun 21, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2018 | Jun 6, 2018 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2018 | May 8, 2018 |
| 10-Q | Quarterly report | May 8, 2018 | Mar 31, 2018 |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 21, 2018 |
| 8-K |
Current report
Other events
|
Apr 27, 2018 | Apr 27, 2018 |
| CT ORDER | Filing | Apr 12, 2018 | — |
| 8-K |
Current report
Other events
|
Apr 9, 2018 | Apr 3, 2018 |
| 8-K |
Current report
Officer or director change
|
Apr 4, 2018 | Apr 3, 2018 |
| 8-K/A | Amended current report | Mar 2, 2018 | Mar 1, 2018 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OPK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC filer status
- Accelerated filer
- SEC CIK
- 944809
- Former names
- EXEGENICS INC (until Jun 13, 2007); eXegenics Inc (until Jun 13, 2007); CYTOCLONAL PHARMACEUTICS INC /DE (until Jun 4, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.